Trademark: 75174596
Status Date
Saturday, January 5, 2008
Registration Number
2441196
Registration Date
Tuesday, April 3, 2001
Filing Date
Monday, September 30, 1996
Published for Opposition
Tuesday, November 11, 1997
Cancellation Date
Saturday, January 5, 2008
42 clinically tracking, monitoring and reviewing cancer chemotherapy drugs being utilized in the treatment of cancer, namely, prospectively reviewing cancer chemotherapy drug protocols, collecting pertinent and defined clinical data, and compiling and reporting of clinical data to health care providers and insurers to ensure that appropriate and cost effective therapy and treatment is being provided to cancer patients
The drawing is lined for the color purple, fading from dark purple on the left to no color on the right. The broken line long the right edge of the triangle is intended to show where the color fades out and is not part of the mark.
Jan 5, 2008
Cancelled Sec. 8 (6-Yr)
Nov 22, 2006
Case File In Ticrs
Apr 3, 2001
Registered-Principal Register
Oct 11, 2000
Allowed Principal Register - Sou Accepted
Oct 10, 2000
Assigned To Examiner
Oct 4, 2000
Statement Of Use Processing Complete
Oct 2, 2000
Extension 5 Granted
Aug 3, 2000
Use Amendment Filed
Aug 3, 2000
Extension 5 Filed
Mar 31, 2000
Extension 4 Granted
Jan 31, 2000
Extension 4 Filed
Aug 27, 1999
Extension 3 Granted
Aug 3, 1999
Extension 3 Filed
Jan 27, 1999
Extension 2 Granted
Jan 11, 1999
Extension 2 Filed
Jul 30, 1998
Extension 1 Granted
Jul 13, 1998
Extension 1 Filed
Feb 3, 1998
Noa Mailed - Sou Required From Applicant
Nov 11, 1997
Published For Opposition
Oct 10, 1997
Notice Of Publication
Sep 11, 1997
Approved For Pub - Principal Register
Aug 29, 1997
Correspondence Received In Law Office
Feb 27, 1997
Non-Final Action Mailed
Feb 21, 1997
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
